| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00134-008-1024-9 |
| P698 | PubMed publication ID | 18283431 |
| P2093 | author name string | Go Haraguchi | |
| Mitsuaki Isobe | |||
| Yasuhiro Maejima | |||
| Masayuki Yoshida | |||
| Jun-Ichi Suzuki | |||
| Hisanori Kosuge | |||
| Takasuke Imai | |||
| P2860 | cites work | Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1. | Q51112774 |
| DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats. | Q54463500 | ||
| APOE polymorphism is associated with risk of severe sepsis in surgical patients. | Q54632183 | ||
| Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection | Q77223649 | ||
| Pioglitazone prevents acute and chronic cardiac allograft rejection | Q83877639 | ||
| Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality | Q24676668 | ||
| Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients | Q28192865 | ||
| The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma | Q28241580 | ||
| Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells | Q28577122 | ||
| Reversing established sepsis with antagonists of endogenous high-mobility group box 1. | Q35122534 | ||
| Balance of inflammatory cytokines related to severity and mortality of murine sepsis. | Q35529633 | ||
| Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation | Q36371379 | ||
| The disconnect between animal models of sepsis and human sepsis | Q36614258 | ||
| Lipoproteins in inflammation and sepsis. II. Clinical aspects. | Q36648784 | ||
| Lipoproteins in inflammation and sepsis. I. Basic science | Q36648788 | ||
| Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats. | Q40432076 | ||
| PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice | Q40715078 | ||
| Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism | Q40792769 | ||
| Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction | Q41843180 | ||
| Pretreatment with peroxysome proliferator-activated receptor alpha agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock. | Q43648347 | ||
| Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways | Q43748365 | ||
| Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice | Q44752792 | ||
| Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock | Q44771448 | ||
| Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin | Q44848530 | ||
| Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury | Q44934421 | ||
| The last 100 years of sepsis | Q44996293 | ||
| Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice | Q45140669 | ||
| Reduction in alveolar macrophages attenuates acute ventilator induced lung injury in rats | Q45167720 | ||
| A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model | Q45862083 | ||
| Statin treatment after onset of sepsis in a murine model improves survival | Q46584997 | ||
| Apolipoprotein E suppresses the type I inflammatory response in vivo | Q46716863 | ||
| Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway | Q46882606 | ||
| Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors | Q46930716 | ||
| A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats | Q46962193 | ||
| Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis | Q50117510 | ||
| Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. | Q50471451 | ||
| P433 | issue | 7 | |
| P921 | main subject | sepsis | Q183134 |
| knockout mouse | Q1364740 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 1304-1312 | |
| P577 | publication date | 2008-02-19 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis | |
| P478 | volume | 34 |
| Q33604169 | Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock |
| Q38983939 | Effect of creatine and pioglitazone on Hk-2 cell line cisplatin nephrotoxicity |
| Q41600866 | Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury. |
| Q27027464 | Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis |
| Q37910249 | Immunomodulatory therapy for severe influenza |
| Q37684850 | Lipid Use and Misuse by the Heart. |
| Q35761448 | Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? |
| Q30392708 | Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice. |
| Q43224202 | Pioglitazone attenuates ischemia/reperfusion-induced liver injury in rats |
| Q37637714 | Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis |
| Q99727903 | Presence of the apolipoprotein E-ε4 allele is associated with an increased risk of sepsis progression |
| Q30375496 | TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. |
| Q57212511 | The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice |
| Q28481589 | Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections |
| Q37363093 | Year in review in Intensive Care Medicine, 2008: II. Experimental, acute respiratory failure and ARDS, mechanical ventilation and endotracheal intubation |
Search more.